GSK-2881078
- Generic Name
- GSK-2881078
- Drug Type
- Small Molecule
- Chemical Formula
- C14H13F3N2O2S
- CAS Number
- 1539314-06-1
- Unique Ingredient Identifier
- 47M5ZXU844
Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 97
- Registration Number
- NCT03359473
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078
- First Posted Date
- 2015-10-05
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 108
- Registration Number
- NCT02567773
- Locations
- 🇺🇸
GSK Investigational Site, Overland Park, Kansas, United States
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 99
- Registration Number
- NCT02045940
- Locations
- 🇺🇸
GSK Investigational Site, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath